ArticleBMJ paediatrics open2026
Power of their stories: faces of kernicterus - experience and perception of caregivers and their children in Northern Nigeria.
Article in BMJ paediatrics open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundOur qualitative study was conducted to explore real-life experiences and challenges of caregivers and individuals with kernicterus spectrum disorder (KSD) in Northern Nigeria, where it remains a significant cause of neurological impairment. The lived experiences of affected individuals and their caregivers are largely undocumented. These stories of caregivers living with children with KSD and survivors with KSD highlight challenges and obstacles they face beyond bilirubin levels and quantitative measures.
methodsWe conducted focus group discussions (FGDs; n=7), caregivers (n=54 or 6-8 per FGD) and case studies (n=4 individuals with KSD). Data were analysed using thematic analysis at three teaching hospitals in Northern Nigeria, all members of the Stop Kernicterus and Infection in Northern Nigeria+ collaborative. Caregivers with a child who had acute bilirubin encephalopathy and now has KSD and those living with KSD were interviewed.
resultsKey features identified among caregivers were remarkably limited awareness of neonatal jaundice (NNJ) and its consequences, as well as reliance on traditional remedies, resulting in delays accessing care and pervasive stigma. Caregivers reported significant physical, long-term emotional and financial burdens, while individuals with KSD faced real-life challenges with mobility, communication and social inclusion. Despite these obstacles, participants demonstrated incredible resilience and inspiring aspirations.
conclusionsOur study highlights the lives and stories of caregivers and individuals affected by KSD and the urgent need for public health interventions that could prevent KSD through timely access to screening, diagnosis and treatment of NNJ. For those individuals who do progress to KSD, we need not only improved care and support for caregivers but also to value their stories, insisting they not be victimised but given every opportunity to achieve their dreams and full potential.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.